We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
UK healthcare cost-effectiveness panel the National Institute for Health and Clinical Excellence (NICE) has continued to question the value of innovative treatments for Alzheimer's disease.
Organon, a division of Akzo Nobel NV, announced that it has entered a licence agreement with US-based company Genaissance Pharmaceuticals on pharmacogenetic research.
Bayer HealthCare today announced that Avelox® IV (moxifloxacin HCl, solution for Infusion) was approved for the treatment of complicated Skin and Skin Structure Infections (cSSSI).
Bilcare Ltd has acquired ProClinical Inc. of USA. With this acquisition Bilcare enters the Pharma heartland of USA wherein 40 per cent of world pharma activities take place.
A delegation of Pakistani pharmaceutical manufacturers is arriving in Tashkent on 15 July, a press release of the embassy of Pakistan in Tashkent said.
The pharmaceutical industry at large has vehemently opposed the proposed recommendation by the task force on drug affordability that medicines should be prescribed by their generic names.
Egypt's healthcare spending has risen rapidly in recent years, reaching EGP5.6bn (US$900mn) in 2004, but the system is still widely reported to be in poor condition.